JPRN-jRCT2080221521未知1 期
A Phase I, Randomized, Double-Blind, Placebo-Controlled Trial of Single and Multiple Doses of TAS-114 in Healthy Adult Male Subjects
适应症
试验速览
- 阶段
- 1 期
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 39age old(—)
- 性别
- Male
入选标准
- •Healthy male subject who have given written informed consent
- •- Subject's age of twenty years old or more and less than forty years old
- •- Subject's weight of 50.0kg or more and BMI (Body Mass Index) of 18.0-25.0kg/m2
排除标准
- •- Subject with a history or concurrent status of allergic reaction
- •- Subject with a history or concurrent status of alcoholic or drug addiction
- •- Subject who is not willing to stop smoking during hospitalization
- •- Subject who recieved other investigational drug within 180 days before receiving the study drug
研究者
相似试验
尚未招募
1 期
A Phase I Study of AV-1959R, an Amyloid Beta Vaccine in Healthy ParticipantsNeurological - Alzheimer's diseaseAlzheimer's DiseaseACTRN12624000737538Arvax Pty Ltd16
尚未招募
1 期
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Oral Doses of ACT004 in Healthy Adult SubjectsACTRN12622001507774Accendatech AU Pty Ltd.82
已完成
不适用
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study To Assess The Safety, Tolerability, Pharmacokinetics Of Two Monoclonal Antibodies In Healthy VolunteersNL-OMON51340Aerium Therapeutics80
招募中
1 期
A Study to Evaluate the Safety of BW-00163 in Healthy and Mild Hypertension SubjectsCardiovascular - HypertensionHypertensionACTRN12623000023651ARGO BIOPHARMA AUSTRALIA PTY LTD56
招募中
1 期
A first in human study to Evaluate the Safety and Tolerability of OLX75016 for treatment of nonalcoholic steatohepatitis (NASH) and liver fibrosis.(NAFLD) to steatohepatitis (NASH)fibrosisOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonCirrhosisACTRN12624000023550OliX AU Pty Ltd70
